Effects of Dantrolene Treatment on Ventricular Electrophysiology and Arrhythmogenesis in Rats With Chronic β-Adrenergic Receptor Activation

Abstract

Dantrolene, which is primarily used to treat malignant hyperthermia, has recently been suggested for the prevention of arrhythmogenesis in various animal models. In this study, the effects of dantrolene treatment on electrophysiological properties and ventricular arrhythmias (VAs) in rats with chronic β-adrenergic receptor (β-AR) activation were investigated. Rats were randomized to treatment with saline (control group), isoproterenol (ISO; ISO group), or ISO + dantrolene (ID group) for 2 weeks. An electrophysiological study was performed to assess action potential duration restitution (APDR) and induce action potential duration (APD) alternans or VA in vitro. The protein levels of Cav1.2, sarcoplasmic reticulum Ca²⁺-ATPase (SERCA2a), and ryanodine receptor 2 (RyR2) were detected by Western blot. Compared with the control group, chronic administration of ISO significantly increased APD, the maximum slope (S_max) of APDR curve, and the spatial dispersions of S_max and APD (all P < .01), and all effects were attenuated by dantrolene treatment (all P < .05). Additionally, chronic ISO administration significantly reduced the protein levels of SERCA2 and RyR2, but increased the Cav1.2 protein expression (all P < .05). However, compared with the ISO group, dantrolene treatment preserved SERCA2a and RyR2 protein levels and decreased Cav1.2 protein levels in the ID group (all P < .05). The intracellular Ca²⁺ ([Ca²⁺]_i) levels measured by incubating isolated cardiomyocytes with Fluo-3/alveolar macrophages were significantly increased in the ISO group compared with the control group (P < .01). Dantrolene treatment markedly reduced the rise of [Ca²⁺]_i levels caused by chronic administration of ISO (P < .05). Dantrolene treatment also prevented the reductions in the APD alternans and VA thresholds induced by chronic ISO stimulation (all P < .05). These data suggest that dantrolene stabilizes ventricular electrophysiological characteristics and increases the expression of key sarcoplasmic reticulum calcium cycling proteins to reduce vulnerability to VA in rats with chronic β-AR activation.

Keywords

dantrolene isoproterenol electrophysiology ventricular arrhythmia

Introduction

Chronically elevated catecholamine levels have been detected in several cardiovascular diseases, such as congestive heart failure and acute myocardial infarction.^1,2 In these cardiovascular diseases, elevated catecholamine can activate the cardiac β-adrenergic receptor (β-AR), which is a powerful regulator of cardiac function. Although the initial activation of β-AR by catecholamine is beneficial to cardiovascular function, its long-term effects on the heart are harmful. In animals with β-AR overactivation, distinct alterations in myocardial structure and in contractile and electrophysiological properties have been observed.^3
–5 As a nonselective β-AR agonist, isoproterenol (ISO) has been widely used to investigate the effects of activating cardiac β-AR in experimental studies. The ISO acts through the β-AR/cyclic adenosine monophosphate/protein kinase A pathway to increase intracellular Ca²⁺ ([Ca²⁺]_i) levels and eventually lead to [Ca²⁺]_i overload.^6,7 There is evidence to suggest that the aberrant [Ca²⁺]_i homeostasis is a contributor not only to cardiac dysfunction but also to arrhythmogenesis.^8,9 Thus, certain therapeutic interventions to restore the proper [Ca²⁺]_i regulation may potentially prevent the cardiotoxic effects induced by chronic β-AR activation.

Dantrolene, a drug primarily used to treat malignant hyperthermia, has recently been shown to improve cardiac function and prevent arrhythmogenesis via stabilization of ryanodine receptor 2 (RyR2) function and restoration of [Ca²⁺]_i homeostasis in various animal models.^10
–12 Furthermore, a previous study demonstrated that dantrolene treatment has a significant role in protecting the heart against ISO-induced myocardial injury.¹³ However, the effects of dantrolene treatment on electrophysiological properties and ventricular arrhythmia (VA) in animals with chronic β-AR activation remain unclear.

In the present study, we mimicked β-AR overactivation using chronic administration of ISO and examined the effects of dantrolene treatment on ventricular repolarization, action potential duration restitution (APDR), threshold levels of action potential duration (APD) alternans or VA, [Ca²⁺]_i, and expression of key sarcoplasmic reticulum (SR) calcium cycling proteins in rats.

Materials and Methods

Experimental Animals

All experimental procedures conformed to the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH Publication #85-23, revised 1996), and the protocol was approved by the Animal Care and use Committee of Renmin Hospital of Wuhan University, China.

Adult male Sprague-Dawley rats (weighing from 200 to 250 g) from the Experimental Animal Center of the Medical College of Wuhan University were used in this study. The animals were randomly divided into 1 of the following 3 groups: the control group where rats received an equal volume of 0.9% saline; the ISO group where rats received ISO alone (5 mg/kg/d, intraperitoneally [ip]); or the ISO + dantrolene group (ID group) where rats received ISO (5 mg/kg/d, ip) and dantrolene (2 mg/kg/d, ip). Drugs or saline treatments were administered for 14 consecutive days (1/3 total doses every 8 hours). Dantrolene treatment was initiated 30 minutes prior to ISO administration.

Surface Electrocardiogram Recording and Echocardiography Analysis

After the 2-week drug treatment period, surface electrocardiogram (ECG) recordings (lead II) were obtained. Rats were anesthetized with pentobarbital sodium (40 mg/kg, ip) and electrodes were positioned subcutaneously. Chart 7.0 software (AD Instruments, Bella Vista, New South Wales, Australia) was used to analyze the recorded ECG data. Means were calculated for the RR interval, QRS duration, and QT interval. The QT interval was corrected for heart rate using Bazett formula¹⁴ QTc = QT/(RR/100)^1/2.

Additionally, echocardiography analysis was also performed to assess left ventricular ejection fraction (LVEF), left ventricular endocardial fractional shortening (LVEFS), left ventricular end-diastolic diameter (LVEDD), left ventricular end-systolic diameter (LVESD), left ventricular posterior wall dimensions (LVPWD), and interventricular septum thickness at diastole (IVSD) in this study.

Histological Analysis

Rat hearts (n = 5 in each group) were excised and transversely cut close to the papillary muscles to visualize the left ventricles. Heart tissue sections were fixed in 10% phosphate-buffered formalin and embedded in paraffin. Paraffin sections were stained with Masson trichrome to visualize collagen deposition. Fibrosis was quantified in each heart section as the average myocardial interstitial collagen volume fraction (CVF) in 4 random areas of the left ventricular free wall. The CVF was measured by 2 independent observers who were blinded to experimental group assignment, and the mean CVF for each sample was calculated.

Isolation of Ventricular Myocytes and Measurement of [Ca²⁺]_i Levels

As previously described,¹⁵ the ventricular myocytes were obtained from rat hearts (n = 5 in each group) through enzymatic digestion with collagenase. The dissociated cells were used for experiments within 5 hours of preparation.¹⁶ To avoid the cell clumping during the flow cytometry studies, the isolated myocytes were filtered with a 300-μm filter. In addition, cells were stained with propidium iodide (5 μg/mL) to exclude dead cells.¹⁷ Intracellular Ca²⁺ levels were measured as previously reported.^15,16,18 In brief, [Ca²⁺]_i levels were determined using the Ca²⁺-sensitive fluorescence probe, Fluo-3/alveolar macrophage (fluorescence lifetime analysis [FLA]; Molecular Probes; Invitrogen Company, California) by flow cytometry (FACScan, Becton-Dickinson, Massachusetts). The myocytes were incubated with 10 μmol/L FLA at 37°C for 60 minutes. Cells were then washed 3 times with Ca²⁺-free phosphate-buffered saline to remove extracellular FLA before resuspension in Ca²⁺-free media supplemented with 10 mg/mL bovine serum albumin (Gibco Company, California; 145 mmol/L NaCl, 5 mmol/L KCl, 1.0 mmol/L MgCl₂, 1.0 mmol/L ethylene glycol tetraacetic acid [EGTA], 5.6 mmol/L glucose, and 10 mmol/L HEPES, pH 7.4 adjusted with NaOH). Probenecid (2 mmol/L) was added to the media to prevent loss of FLA via the anion transporter.¹⁹ During flow cytometry, FLA fluorescence intensity was measured with a spectrophotometer (Hitachi F-4500, Japan) by exciting the cells at a wavelength of 488 nm and recording the emission signal at a wavelength of 530 nm. Approximately 2 × 10³ cells in each sample were analyzed to calculate the mean fluorescence intensity (F_mean) of FLA, which is positively correlated with the [Ca²⁺]_i level. Additionally, the average [Ca²⁺]_i concentration was calculated by the following equation^16,18,19: [Ca²⁺]_i = K_d[(F − F_min)/(F_max − F)], where K_d is the dissociation constant of FLA (400 nmol/L at 37°C).¹⁹ F_max is the maximal F_mean obtained by adding 0.1% Triton X-100 and 1 mmol/L CaCl₂, and F_min is the minimal F_mean determined by adding 10 mmol/L EDTA. F is the F_mean measured without the addition of Triton-X-100 and CaCl₂ or EGTA.

Western Blotting Analysis

Rat hearts (n = 5 in each group) were immediately excised following euthanasia. The left ventricular tissue was then collected and stored in tubes at −80°C until Western blotting analysis was performed. Western blotting was performed to determine the relative expression levels of Cav1.2, RyR2, sarcoplasmic reticulum Ca²⁺-ATPase (SERCA2a), and phospholamban (PLB). In this study, the protein levels were normalized to glyceraldehyde 3-phosphate dehydrogenase.

Preparation of Langendorff-Perfused Hearts

The rats were anesthetized with pentobarbital sodium (40 mg/kg, ip) and heparinized with heparin sodium (400 U, ip). After a thoracotomy, the heart was quickly isolated, rapidly cannulated in a Langendorff perfusion system (AD Instruments) and secured for retrograde perfusion with 37.0°C ± 0.5°C oxygenated Tyrode solution at a rate of 6 to 8 mL/min. The composition of Tyrode solution was as previously described.²⁰ Prior to further analysis, the isolated hearts were perfused for 20 minutes. Those hearts that had irreversible myocardial ischemia or did not recover regular spontaneous rhythm were discarded. A total of 36 hearts (n = 12 in each group) were used for further experimental procedures in this study.

Data Acquisition and Stimulation Protocol

Monophasic action potential recording

The monophasic action potential (MAP) was recorded in 4 epicardial sites using a custom-made Ag-AgCl electrode, which was comprised of two 0.25-mm Teflon-coated silver wires (99.99% purity).²⁰ The 4 recording sites included the left ventricular anterior and posterior base and the left anterior apex and left posterior apex (LPA). All MAP signals were recorded and analyzed by the PowerLab system and Chart 7.0 software (AD Instruments). The amplifier bandwidth signal was between 0.3 and 1 kHz.

S₁ dynamic pacing, inducibility of APD alternans or VA, and construction of APDR curves

The paired platinum-stimulating electrodes were positioned on the basal surface of the right ventricle, and the pacing stimuli were 2-ms pulse widths with 3 times the diastolic threshold current. The S₁-S₁ pacing protocol was performed with a series of pulse trains at a regular pacing cycle length (PCL). Starting at 300 ms, the PCL was shortened to 160 ms in 20-ms intervals and then to 40 ms in 10-ms intervals. The regular pacing at each PCL lasted for 15 seconds to ensure a steady rhythm, and each pacing was separated by at least 30 seconds to minimize the pacing memory. The VA episode was defined as lasting >2 seconds.⁴ If VA was induced, a 5- to 10-minute rest period after VA termination allowed for cardiac electrical recovery. The APD at the PCL of 300 ms in each site was determined at 90% repolarization (APD₉₀) to calculate the average APD₉₀ of the left ventricle. The APD alternans was assessed at each site by subtracting the APD₉₀ for 2 consecutive beats when the alternate APD₉₀ differed by >5% over 10 beats.²¹ The threshold was defined as the maximal PCL (PCL_max) that induced APD alternans or VA by PCL decrease. When the PCL was decreased to 40 ms, but the APD alternans or VA was not elicited, the threshold of APD alternans or VA was defined as less than 40 ms.

The dynamic APDR curves were constructed by plotting each APD₉₀ against the preceding diastolic interval (DI), and the data points were fitted with a single exponential trend as in previous reports.^21,22 The DI was measured between the APD₉₀ point in the preceding MAP and the onset of the subsequent MAP. The maximal slopes (S_maxs) of the APDR curves were determined at the shortest DI. Traces in which a reproducible sequence of consistently shaped waveforms could not be obtained were not used to construct APDR curves.

Statistical Analysis

SPSS 18.0 for Windows (SPSS Inc, Chicago, Illinois) was used for the statistical analyses. The coefficients of variation (COVs, standard deviation [SD]/mean) of the APD₉₀ and S_max curves were calculated to represent the spatial dispersions of APD₉₀ and S_max in the left ventricle. Continuous data, that is, APD₉₀, COV, and CVF, were expressed as the mean ± SD and analyzed by 1-way analysis of variance followed by Tukey post hoc test to determine the differences among groups. The median threshold values of APD alternans or VA were compared by the nonparametric Wilcoxon signed rank test or the Kruskal-Wallis test as appropriate. The nonlinear curve fit to construct the APDR curve was created with Origin7.5 (Microcal Co Inc, Northampton). A value of P < .05 was considered statistically significant.

Results

Changes in Cardiac Structural and Contractile Function

Table 1 summarizes the body and organ weights of the rats in each group. With respect to body weight, no differences were found among the 3 groups (all P > .05). However, chronic ISO administration significantly increased the heart weight (HW) and left ventricular weight (LVW; all P < .01 compared to the control group). By contrast, significant reductions in HW and LVW were found in the ID group when compared to the ISO group (all P < .01). Additionally, echocardiography showed that chronically ISO-stimulated rats exhibited significantly increased LVEDD, LVESD, IVSD, and LVPWD, while the LVEF and LVEFS values were significantly decreased (all P < .01, compared to the control group). However, dantrolene administration ameliorated the abnormal echocardiographic indices induced by chronic ISO stimulation (all P < .05; Table 1). Consistent with these results, histopathology of the heart sections showed that the average myocardial interstitial CVF was also markedly increased in the ISO group when compared with the control group (P < .01). In contrast, the CVF was lower in the ID group than in the ISO group (P < .01; Figure 1).

Table 1.

The ECG, Anatomic, and Echocardiographic Parameters in Each Group.

Parameters	Control Group, n = 6	ISO Group, n = 6	ID Group, n = 6
RR interval, ms	166.50 ± 2.88	183.67 ± 7.97^a	175.50 ± 3.62^b
QRS duration, ms	19.83 ± 1.17	24.83 ± 1.72^a	22.17 ± 1.47^b
QT interval, ms	47.83 ± 1.94	66.17 ± 2.79^a	53.50 ± 2.07^c
QTc	37.07 ± 1.32	48.85 ± 2.35^a	40.40 ± 1.84^c
HR, beat/min	360.45 ± 6.24	327.17 ± 13.73^a	341.99 ± 6.93^b
BW, g	348.83 ± 5.91	355.17 ± 5.81	352.50 ± 5.68
HW, g	1.17 ± 0.02	1.52 ± 0.08^a	1.37 ± 0.05^c
HW/BW, mg/g	3.34 ± 0.07	4.28 ± 0.26^a	3.89 ± 0.14^c
LVW, g	0.70 ± 0.04	1.01 ± 0.06^b	0.88 ± 0.05^c
LVW/BW, mg/g	2.00 ± 0.10	2.85 ± 0.21^a	2.51 ± 0.14^c
LVEDD, mm	6.23 ± 0.07	8.43 ± 0.06^a	7.63 ± 0.14^c
LVESD, mm	3.48 ± 0.08	5.96 ± 0.14^a	4.88 ± 0.12^c
LVPWD, mm	2.03 ± 0.09	2.53 ± 0.12^a	2.30 ± 0.10^c
IVSD, mm	2.00 ± 0.08	2.48 ± 0.11^a	2.28 ± 0.10^c
LVEF, %	78.17 ± 4.45	41.33 ± 4.41^a	52.33 ± 4.32^c
LVEFS, %	44.17 ± 3.43	29.50 ± 3.27^a	34.50 ± 3.08^b

Abbreviations: BW, body weight; ECG, electrocardiogram; HR, heart rate; HW, heart weight; ID, ISO + dantrolene; ISO, isoproterenol; IVSD, interventricular septum thickness at diastole; LVEDD, left ventricular end-diastolic diameter; LVEF, left ventricular ejection fraction; LVEFS, left ventricular endocardial fractional shortening; LVESD, left ventricular end-systolic diameter; LVPWD, left ventricular posterior wall dimensions; LVW, left ventricular weight.

^a P < .01 versus control group.

^b P < .05 versus ISO group.

^c P < .01 versus ISO group.

Figure 1.

Histological analysis of myocardial fibrosis in 3 groups. A, Masson trichrome stain shown (magnification of ×400) in the left ventricles; (B) summarized data of myocardial fibrosis in each group. Chronic ISO administration significantly increased the myocardial interstitial average collagen volume fraction (CVF) in the ISO group. In contrast, dantrolene treatment markedly reduced the CVF in the ISO + dantrolene (ID) group.*P < .01 versus control group; ^# P < .01 versus ISO group. ISO indicates isoproterenol.

Characteristics of Ventricular Repolarization

Compared with the control group, the ISO group displayed abnormal ECG waveform morphologies, including widened QRS complexes and prolonged QTc and RR and QT intervals (all P < .01). However, dantrolene treatment markedly attenuated these ECG alterations in the ID group compared to the ISO group (all P < .01; Figure 2 and Table 1). Additionally, chronic ISO administration significantly increased the average APD₉₀ and COV-APD₉₀ (all P < .01). In contrast, treatment with dantrolene significantly reduced the average APD₉₀ and COV-APD₉₀ in rats that received chronic ISO administration (all P < .01; Figure 3).

Figure 2.

Three representative electrocardiograms recorded from each group showed the measurements of QRS complex and QT intervals. Dantrolene treatment prevented the electrocardiogram (ECG) waveform abnormalities in the chronically isoproterenol (ISO)-stimulated rats.

Figure 3.

The comparisons of ventricular repolarization among 3 groups. A, Three representative APD recorded from each group; (B) summarized data of average APD₉₀ in 3 groups; (C) the APD₉₀ at 4 recording sites of each group; and (D) the spatial dispersion of APD₉₀ was evaluated by coefficient of variations (COV-APD₉₀) among 4 recording sites. Dantrolene treatment significantly reduced the increase in APD₉₀ and COV-APD₉₀ induced by chronic ISO administration. *P < .01 versus control group; ^# P < .01 versus ISO group. APD₉₀ indicates action potential duration at 90% repolarization; LAB, left anterior basic ventricle; LAA, left anterior apex; LPB, left posterior basic ventricle; LPA, left posterior apex; ISO, isoproterenol.

Alterations in [Ca²⁺]_i Levels and the Expression of Key SR Calcium Cycling Proteins

In this study, the [Ca²⁺]_i level was analyzed by the F_mean and [Ca²⁺]_i concentration. Compared with the control group, the F_mean and [Ca²⁺]_i concentration were markedly augmented in the ISO group (all P < .01). However, the ID group exhibited significant decreases in F_mean and [Ca²⁺]_i concentration when compared to the ISO group (all P < .01; Figure 4).

Figure 4.

The results of [Ca²⁺]_i level in each group. A, The examples of fluorescence lifetime analysis (FLA) fluorescence intensity in each group; (B and C) the comparisons of average fluorescence intensity (F_mean) and [Ca²⁺]_i concentration in each group. Compared to the control group, both the F_mean and [Ca²⁺]_i concentration were significantly increased in the ISO group. However, dantrolene treatment markedly reduced the F_mean and [Ca²⁺]_i concentration in the ISO + dantrolene (ID) group. *P < .01 versus control group; ^# P < .01 versus ISO group. [Ca²⁺]_i indicates intracellular Ca²⁺; ISO, isoproterenol.

Furthermore, as shown in Figure 5, chronic ISO administration significantly reduced the protein levels of SERCA2 and RyR2 but increased the expression of Cav1.2 (all P < .01 compared to the control group). However, compared with the ISO group, dantrolene treatment preserved SERCA2a and RyR2 protein levels and decreased the Cav1.2 protein level in the ID group (all P < .05). There was no significant difference in the PLB protein levels among the 3 groups (all P < .05).

Figure 5.

The expression of Cav1.2, RyR2, SERCA2a, and PLB was assayed by Western blotting. Chronic ISO stimulation significantly decreased SERCA2a and RyR2 protein levels, while increased the Cav1.2 protein levels. However, compared with the ISO group, dantrolene treatment preserved SERCA2a and RyR2 protein levels and decreased Cav1.2 protein levels in the ISO + dantrolene (ID) group. No significant differences in the expression of PLB were found among 3 groups (all P > .05). *P < .01 versus control group; ^# P < .05 and ^## P < .01 versus ISO group. ISO indicates isoproterenol; PLB, phospholamban; RyR2, ryanodine receptor 2; SERCA2a, sarcoplasmic reticulum Ca²⁺-ATPase.

Changes in the APDR Curve and the APD Alternans or VA Thresholds

Figure 6 shows the dynamic APDR curves, and Table 2 summarizes the S_max at the 4 recording sites in each group. Chronic ISO administration remarkably steepened the dynamic APDR curves at each site (all P < .01). In contrast, the dynamic APDR curves were flattened by dantrolene treatment in the ID group compared to the ISO group at each recording site (all P < .01). Chronic ISO administration also increased the COV-S_max compared with the control values (ISO group: 0.18 ± 0.01 vs control group: 0.09 ± 0.01, P < .01). However, dantrolene treatment significantly reduced the increase in COV-S_max induced by chronic ISO administration (ID group: 0.13 ± 0.01 vs ISO group: 0.18 ± 0.01, P < .01).

Figure 6.

The examples of APD restitution curve in each group. Compared to the control group, the APD restitution curves were shifted upward and steepened in the ISO group at all sites. However, the APD restitution curves were shifted downward and flattened in the ISO + dantrolene (ID) group compared to the ISO group at all sites. ISO indicates isoproterenol.

Table 2.

The S_max of APDR Curve at 4 Recording Sites in Each Group.

	LAB	LAA	LPB	LPA
Control, n = 12	0.76 ± 0.04	0.84 ± 0.04	0.91 ± 0.03	0.94 ± 0.03
ISO, n = 12	1.27 ± 0.05^a	1.38 ± 0.05^a	1.60 ± 0.07^a	1.88 ± 0.06^a
ID, n = 12	1.09 ± 0.05^b	1.23 ± 0.07^b	1.38 ± 0.05^b	1.47 ± 0.07^b

Abbreviations: APDR, action potential duration restitution; ID, ISO + dantrolene; ISO, isoproterenol; LAA, left anterior apex; LAB, left ventricular anterior base; LPA, left posterior apex; LPB, left ventricular posterior base; S_max, maximum slope.

^a P < .01 versus control group.

^b P < .01 versus ISO group.

Meanwhile, the ISO group exhibited significant increases in the PCL_max inducing APD alternans or VA at each recording site (all P < .01 compared to the control), indicating that the APD alternans and VA thresholds were markedly reduced by chronic ISO administration. However, the PCL_max inducing APD alternans or VA was shorter in the ID group than in the ISO group (all P < .01), indicating that dantrolene treatment prevented the reduction in APD alternans and VA thresholds induced by chronic ISO stimulation (Figures 7 and 8). Because the PCL inducing VA differed, we did not compare the incidence and duration of VA among the 3 groups.

Figure 7.

The APD alternans was induced in 3 groups. A, The MAPs were recorded in each group at pacing cycle length (PCL) of 200 ms; (B) MAP tracings during the APD alternans in 1 rat of each group. The numbers in all the panels represent APD₉₀; (C) the median of maximal PCL induced APD alternans at 4 sites in each group. Dantrolene treatment prevented the reductions in the APD alternans threshold induced by chronic isoproterenol (ISO) stimulation at all recording sites. APD indicates action potential duration; MAP, monophasic action potential.

Figure 8.

Ventricular arrhythmia (VA) was elicited by S₁-S₁ dynamic pacing in each group. A, The examples of VA in 3 groups; (B) the median of maximal pacing cycle length (PCL) induced VA at 4 sites in each group. Compared to the control value, chronic ISO stimulation significantly decreased the VA threshold at 4 recording sites. However, dantrolene treatment increased the VA threshold in the ISO + dantrolene (ID) group compared to the ISO group (all P < .01). *P < .01 versus control group; ^# P < .01 versus ISO group. ISO indicates isoproterenol.

Discussion

Main Findings

In the present study, we evaluated the effects of dantrolene treatment on ventricular electrophysiology and arrhythmogenesis in rats with chronic β-AR activation. We found that (1) treatment with dantrolene stabilized the cardiac electrophysiological properties of rats treated with chronic ISO stimulation, including shortened APD, flattened the APDR curves, and decreased spatial dispersions of APD₉₀ and S_max; (2) dantrolene administration significantly preserved SERCA2a and RyR2 protein levels and decreased the expression of Cav1.2 and [Ca²⁺]_i levels in chronically ISO-stimulated rats; and (3) dantrolene treatment significantly increased the APD alternans and VA thresholds in rats that received chronic ISO administration.

The Abnormal Changes in ECG After Chronic β-Adrenoceptor Stimulation

The widening of QRS complex and prolongation of QT interval have been reported in this study. Krandycheva et al²³ also showed the widened QRS complex and prolonged QT interval in the ISO-induced heart failure rat model. They demonstrated that the widened QRS complex induced by ISO stimulation was ascribed to the prolongation of epicardial activation duration.²³ In the current study, cardiac fibrosis induced by chronic ISO stimulation might attenuate the electrotonic interaction between ventricular myocytes and hence to increase epicardial activation duration.²³ Therefore, it is possible that cardiac fibrosis induced by ISO might lead to prolongation of QRS duration. Additionally, previous studies reported that ISO administration preferentially damage the subendocardial and midmyocardial layers of the heart ventricles, which could result in the transmural delay of activation and finally create a widened QRS complex.^23
–25 The prolonged QT interval induced by chronic ISO administration in the present study might be due to the prolongation of APD, which probably resulting from downregulation of outward K⁺ currents.³

Dantrolene Attenuated the Abnormal Changes in Ventricular Repolarization Induced by Chronic ISO Stimulation

Soltysinska et al³ reported that chronic ISO stimulation prolonged ventricular repolarization in guinea pig hearts. In this study, we also showed extended ventricular repolarization by chronic ISO stimulation, as evidenced by prolonged APD₉₀ and QT intervals. In addition, similar to the previous studies,^26,27 we found that sustained β-AR stimulation increased the expression of Cav1.2 in ventricular tissue, which may be implicated in the prolonged ventricular repolarization caused by chronic ISO stimulation. However, dantrolene administration was found to attenuate a prolongation of ventricular repolarization induced by chronic ISO stimulation. Dantrolene can reportedly behave as verapamil, an L-type calcium channel blocking agent, to inhibit inward calcium current at adequate dose in cardiac cells.^28
–30 Although a patch-clamp experiment was not performed in this study, we observed that dantrolene treatment decreased the Cav1.2 protein levels in rats that received chronic ISO stimulation, which may result in the reduction of L-type Ca²⁺ current. Therefore, we hypothesize that the effects of dantrolene treatment on the L-type Ca²⁺ current may be implicated in the abbreviated ventricular repolarization observed in this study.

Furthermore, a posterior-to-anterior and apex-to-basal APD₉₀ gradient was present in the ISO group, with the longest duration observed at LPA, resulting in an increased COV-APD₉₀ and suggesting an increased spatial dispersion of APD₉₀. In contrast, the COV-APD₉₀ was significantly decreased by dantrolene treatment in the ID group. The increased spatial dispersion of APD₉₀ has been suggested in previous studies to favor micro reentry and discordant APD alternans and VA.^21,31 Thus, we suggest that the reduction in spatial dispersion of APD₉₀ may be associated with the antiarrhythmic effect of dantrolene treatment.

Dantrolene Prevented APD Alternans via Increased Expression of Key SR Calcium Cycling Proteins in Rats That Received Chronic ISO Stimulation

Previous studies suggested that APD alternans predisposed the ventricle to fibrillation, while a delayed APD alternans was associated with lower susceptibility to VA.^32,33 In this study, we observed that dantrolene treatment significantly increased the APD alternans threshold in rats chronically stimulated with ISO, indicating a potential role for dantrolene in reducing vulnerability to VA. Although the mechanisms of APD alternans have not been completely illuminated, the dysfunctional SR calcium handling hypothesis has been proposed to explain the cellular mechanism of APD alternans.^34
–36 It states that cellular alternans occurs when the heart rate exceeds the ability of myocytes to properly control calcium cycling. The RyR2 and SERCA2a are key SR calcium cycling proteins and critical factors in the generation of APD alternans. Previous studies demonstrated that dysfunctional SR calcium cycling caused by partial inhibition of RyR2 and SERCA2a function can cause [Ca²⁺]_i cycling alternans, which directly implicated calcium cycling in the mechanism of APD alternans.^36
–38 Wan et al³⁴ showed that the expression levels of RyR2 and SERCA2a were lower in alternans-susceptible myocytes than in alternans-resistant myocytes. Moreover, overexpression of SERCA2a in the intact heart has been associated with significant resistance to APD alternans.³⁹ In the current study, dantrolene administration preserved the expression of RyR2 and SERCA2a, which were reduced by chronic ISO stimulation. Thus, we suggest that suppression of APD alternans by dantrolene treatment may be attributed to increased expression of key SR calcium cycling proteins in chronically ISO-stimulated rats.

Dantrolene Stabilized Ventricular APDR Properties to Suppress VA in Rats That Received Chronic ISO Stimulation

The electrical restitution hypothesis suggests that a steep APDR curve slope may precipitate oscillation in APD and electrophysiological instability during rapid pacing, thereby leading to the gradual development of conduction block, spiral wave break, and ventricular fibrillation.^40,41 According to the electrical restitution hypothesis, an increased APDR curve slope is associated with increased vulnerability to VA. Some antiarrhythmic drugs or other interventions that can flatten the APDR curve have been shown to prevent or suppress the occurrence of VA.^42
–44 In the present study, we showed that dantrolene treatment reduced the S_max of the APDR curves obtained in the chronically ISO-stimulated rat model, suggesting a potential antiarrhythmic effect for dantrolene. Intracellular Ca²⁺ dynamics have been proposed to play an important role in APDR.⁴⁵ During periods of fast heartbeat, increased [Ca²⁺]_i accumulation can remarkably reduce the APD at a short DI, owing to [Ca²⁺]_i accumulation induced inactivation of the L-type Ca²⁺ current or increases in the Ca²⁺-dependent outward K⁺ current, or both.^3,46 The balance of APD and previous phase DI can be shifted by [Ca²⁺]_i accumulation and finally result in a steep APDR curve. In this study, dantrolene reduced the [Ca²⁺]_i levels and preserved the expression of SERCA2a and RyR2 in chronically ISO-stimulated hearts, which may reduce the [Ca²⁺]_i accumulation during rapid pacing. Therefore, we presume that the dantrolene-induced decrease in the S_max of APDR curves in chronically ISO-stimulated hearts was partly due to improved [Ca²⁺]_i cycling. However, the detailed mechanism by which dantrolene flattens the APDR curve in chronically ISO-stimulated rats requires further investigation.

Additionally, it has been demonstrated that the APDR curve obtained at a single site may not represent the kinetics of APDR restitution in the whole heart.⁴⁷ Nash et al⁴⁸ showed that the spiral wave break could be caused by the increased spatial differences in S_max. In addition, Lu et al⁴⁹ reported that vagal nerve stimulation precipitated atrial fibrillation associated with an increased spatial difference in S_max. These studies demonstrated that the increased spatial difference in S_max also played an important role in arrhythmogenesis. In the current study, the spatial dispersion of S_max was evaluated by calculating the COV-S_max. We determined that dantrolene treatment decreased the COV-S_max in the chronically ISO-stimulated rat model, also suggesting that dantrolene exerts a protective effect during VA.

Dantrolene Improved the Cardiac Remodeling Induced by ISO Chronic Stimulation

Sustained ISO stimulation causes the excessive production of free radicals, cytosolic Ca²⁺ overload, and severe stress in the myocardial tissue. As shown in previous studies,^50,51 we also observed that chronic ISO stimulation induced cardiac hypertrophy accompanied by enhanced fibrosis among the interstitial cardiac tissue. Both abnormal Ca²⁺ handling and cardiac oxidative stress have been proposed to induce changes in cardiac structure following chronic ISO stimulation.^50,52 Shibata et al⁵² demonstrated that the upregulation of SERCA2a protein levels, which improved the Ca²⁺ handling dysfunction, inhibited the development of cardiac remodeling in chronically ISO-infused rats. Thus, we suggest that the enhanced levels of SERCA2a and RyR2 induced by dantrolene were implicated in ameliorating the cardiac remodeling induced by chronic ISO stimulation. Additionally, Buyukokuroglu et al⁵³ reported that dantrolene has antioxidant properties in a myocardial infarction model. However, whether the antioxidant effects of dantrolene prevent the development of cardiac remodeling requires investigation.

Dantrolene Alleviated the [Ca²⁺]_i Overload Induced by Chronic ISO Stimulation

In this study, dantrolene treatment markedly decreased the elevated [Ca²⁺]_i induced by chronic ISO stimulation, suggested that dantrolene alleviated the [Ca²⁺]_i overload induced by chronic ISO stimulation. Many studies reported that ISO treatment could increase diastolic [Ca²⁺]_i and decrease the SR Ca²⁺ content by reducing the SERCA2a activity and enhancing the Ca²⁺ leak from SR during diastole, these effects may finally result in [Ca²⁺]_i overload.^4,6,7 Bers⁵⁴ demonstrated that SERCA2a pump, which could remove 92% of the activator Ca²⁺ during diastole, plays a pivotal role in regulating the [Ca²⁺]_i cycling in rat cardiac cells. In this study, dantrolene treatment prevented the reduction in SERCA2a protein expression caused by chronic ISO administration, which may be the important action of dantrolene to alleviate the [Ca²⁺]_i overload induced by chronic ISO stimulation in this study. Additionally, recent evidences have suggested that as a stabilizer of RyR function, dantrolene could inhibited diastolic Ca²⁺ leak from SR to restore the proper [Ca²⁺]_i handling in heart failure model.^11,12 Thus, we suggest that dantrolene alleviated [Ca²⁺]_i overload may also via reducing the diastolic Ca²⁺ leak from SR in the present study.

Clinical Implications

Progression of chronic heart failure and myocardial infarction is accompanied by electrical remodeling, which could promote the development of potentially lethal VA and sudden cardiac death. It has been shown that catecholamine levels are chronically elevated in patients with chronic heart failure and myocardial infarction. Increased plasma catecholamine levels can activate the β-AR and hence affect cardiac function. Both our previous report and other studies have demonstrated that chronic activation of the β-AR can distinctly alter cardiac electrophysiological properties and facilitate VA.^3,4 Thus, the increased catecholamine levels might well play a pathogenic role in electrical remodeling during chronic heart failure and myocardial infarction. Meanwhile, certain therapeutic interventions that attenuate the electrical remodeling caused by chronic β-AR activation may be beneficial for reducing the incidence of VA and sudden death in patients with chronic heart failure and myocardial infarction. In this study, we showed that dantrolene treatment stabilizes the ventricular electrophysiological properties to reduce the vulnerability to VA in rats with chronic β-AR activation, indicating that dantrolene may be a promising antiarrhythmic drug for preventing VA in these cardiovascular diseases.

Study Limitations

There are several limitations to the present study. First, we determined only electrophysiological characteristics at epicardial sites, but the electrophysiological properties between the epicardium to endocardium are different, and whether dantrolene treatment affects endocardial ventricular electrophysiological properties in the chronically ISO-stimulated model remains unknown. Second, although previous studies have demonstrated that dantrolene can inhibit the L-type Ca²⁺ current at adequate dose, whether the dose of dantrolene used in this study is sufficient to directly reduce the L-type Ca²⁺ current is still unclear, further research is needed to assess the changes in the L-type Ca²⁺ current by the dose of dantrolene used in this study. Third, we determined only the changes in RyR2 and SERCA2a protein expression and [Ca²⁺]_i levels to indirectly assess the SR calcium cycling, but the calcium transient recording, which can directly assess the SR calcium cycling, was not assessed in this study. Fourth, it is well known that ventricular repolarization characteristics of rat ventricular cells differ from that of human ventricular cells. Unlike human hearts, rat hearts exhibit a short duration of ventricular repolarization and a triangular shape of action potential and lack a well-defined plateau phase during repolarization, which is attributed to the differently predominated outward K⁺ current contributing to ventricular repolarization. The major ionic current greatly mediating the ventricular repolarization of rat hearts is transient outward K⁺ current (I_to), whereas the fast and the slow components of delayed rectifier K⁺ currents (I_Kr and I_Ks) play an important role in ventricular repolarization of human hearts.^3,55,56 Therefore, the electrophysiological findings obtained from rat hearts in this study can’t directly be extrapolated to human hearts.

Conclusions

The present study demonstrates the effects of dantrolene treatment on ventricular electrophysiological properties and arrhythmogenesis in rats with chronic β-AR activation. These data suggest that dantrolene treatment stabilizes ventricular electrophysiological characteristics and increases the expression of key SR calcium cycling proteins to reduce vulnerability to VA in rats with chronic β-AR activation.

Footnotes

Author Contributions

T. Liu contributed to conception and design, analysis, drafted the article, gave final approval, and agreed to be accountable for all aspects of work ensuring integrity and accuracy. S.-B. Shi contributed to conception, acquisition and interpretation, drafted the article, gave final approval, and agreed to be accountable for all aspects of work ensuring integrity and accuracy. M. Qin contributed to design, acquisition and interpretation, critically revised the article, gave final approval, and agreed to be accountable for all aspects of work ensuring integrity and accuracy. C. X. Huang contributed to conception and design, acquisition, analysis, and interpretation, critically revised the article, gave final approval, and agreed to be accountable for all aspects of work ensuring integrity and accuracy. T. Liu and S.-B. Shi contributed equally to this work.

Declaration of Conflicting Interests

The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Funding

The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by the National Key Basic Research Development Program of China (The “973” Program; no. 2012CB518604), Natural Science Foundation of Hubei Province China (no. 2013CFA117), and the Fundamental Research Funds for the Central Universities of China (no. 2014302020201). This study also supported by the China Scholarship Council.

References

Grassi

Seravalle

Bertinieri

. Sympathetic and reflex abnormalities in heart failure secondary to ischaemic or idiopathic dilated cardiomyopathy. Clin Sci. 2001;101(2):141–146.

Graham

Smith

Stoker

Mackintosh

Mary

. Time course of sympathetic neural hyperactivity after uncomplicated acute myocardial infarction. Circulation. 2002;106(7):793–797.

Soltysinska

Olesen

Osadchii

. Myocardial structural, contractile and electrophysiological changes in the guinea-pig heart failure model induced by chronic sympathetic activation. Exp Physiol. 2011;96(7):647–663.

Qin

Liu

Wang

Huang

. Effect of isoprenaline chronic stimulation on APD restitution and ventricular arrhythmogenesis. J Cardiol. 2013;61(2):162–168.

Osadchii

. Cardiac hypertrophy induced by sustained beta-adrenoreceptor activation: pathophysiological aspects. Heart Fail Rev. 2007;12(1):66–86.

Meng

Feng

Chen

Yang

Zhang

. Trimetazidine improved Ca²⁺ handling in isoprenaline mediated myocardial injury of rats. Exp Physiol. 2006;91(3):591–601.

Shen

. Isoprenaline enhances local Ca²⁺ release in cardiac myocytes. Acta Pharmacol Sin. 2006;27(7):927–932.

Liu

Priori

. Disruption of calcium homeostasis and arrhythmogenes is induced by mutations in the cardiac ryanodine receptor and calsequestrin. Cardiovasc Res. 2008;77(2):293–301.

del Monte

Lebeche

Guerrero

. Abrogation of ventricular arrhythmias in a model of ischemia and reperfusion by targeting myocardial calcium cycling. Proc Natl Acad Sci. 2004;101(15):5622–5627.

10.

Kobayashi

Yano

Uchinoumi

. Dantrolene, a therapeutic agent for malignant hyperthermia, inhibits catecholaminergic polymorphic ventricular tachycardia in a RyR2(R2474S/+) knock-in mouse model. Circ J. 2010;74(12):2579–2584.

11.

Maxwell

Domeier

Blatter

. Dantrolene prevents arrhythmogenic Ca²⁺ release in heart failure. Am J Physiol Heart Circ Physiol. 2012;302(4):H953–H963.

12.

Kobayashi

Yano

Suetomi

. Dantrolene, a therapeutic agent for malignant hyperthermia, markedly improves the function of failing cardiomyocytes by stabilizing interdomain interactions within the ryanodine receptor. J Am Coll Cardiol. 2009;53(21):1993–2005.

13.

Acikel

Buyukokuroglu

Erdogan

Aksoy

Bozkurt

Senocak

. Protective effects of dantrolene against myocardial injury induced by isoproterenol in rats: biochemical and histological findings. Int J Cardiol. 2005;98(3):389–394.

14.

Zhang

Dipika

. Functional roles of Cav1.3 (1D) calcium channels in atria insights gained from gene-targeted null mutant mice. Circulation. 2005;112(13):1936–1944.

15.

Sugishita

Philipson

Barry

. Gender influences [Ca²⁺] _i during metabolic inhibition in myocytes overexpressing the Na⁺ –Ca²⁺ exchanger. Circulation. 2001;104(17):2101–2106.

16.

Sugishita

Barry

. Anti-oxidant effects of estrogen reduce [Ca²⁺] _i during metabolic inhibition. J Mol Cell Cardiol. 2003;35(3):331–336.

17.

Sharikabad

Aronsen

Haugen

. Cardiomyocytes from postinfarction failing rat hearts have improved ischemia tolerance. Am J Physiol Heart Circ Physiol. 2009;296(3):H787–H795.

18.

Sugishita

Ueda

Barry

. Activation of connexin-43 hemichannels can elevate [Ca²⁺] _i and [Na(+)] _i in rabbit ventricular myocytes during metabolic inhibition. J Mol Cell Cardiol. 2001;33(12):2145–2155.

19.

Tanaka

Tomisato

Hoshino

. Involvement of intracellular Ca²⁺ levels in nonsteroidal anti-inflammatory drug-induced apoptosis. J Biol Chem. 2005;280(35):31059–31067.

20.

Liu

Qin

Shi

Chen

Wang

Huang

. Effects of endothelin-1 chronic stimulation on electrical restitution, beat-to-beat variability of repolarization, and ventricular arrhythmogenesis. J Cardiovasc Pharmacol. 2013;62(6):549–558.

21.

Martin

Grace

Huang

. Spatial and temporal heterogeneities are localized to the right ventricular outflow tract in a heterozygotic Scn5a mouse model. Am J Physiol Heart Circ Physiol. 2011;300(2):H605–H616.

22.

Banville

Chattipakorn

Gray

. Restitution dynamics during pacing and arrhythmias in isolated pig hearts. J Cardiovasc Electrophysiol. 2004;15(4):455–463.

23.

Krandycheva

Kharin

Strelkova

Shumikhin

Sobolev

Shmakov

. Ventricular repolarization in a rat model of global heart failure. Clin Exp Pharmacol Physiol. 2013;40(7):431–437.

24.

Benjamin

Jalil

Tan

Cho

Weber

Clark

. Isoproterenol-induced myocardial fibrosis in relation to myocyte necrosis. Circ Res. 1989;65(3):657–670.

25.

Tran

. p38 alpha mitogen-activated protein kinase inhibition improves cardiac function and reduces myocardial damage in isoproterenol-induced acute myocardial injury in rats. J Cardiovasc Pharmacol. 2004;44(4):486–492.

26.

Akuzawa-Tateyama

Tateyama

Ochi

. Sustained beta-adrenergic stimulation increased L-type Ca²⁺ channel expression in cultured quiescent ventricular myocytes. J Physiol Sci. 2006;56(2):165–172.

27.

Maki

Gruver

Davidoff

. Regulation of calcium channel expression in neonatal myocytes by catecholamines. J Clin Invest. 1996;97(3):656–663.

28.

Salata

Wasserstrom

Jalife

. Dantrolene sodium: effects on isolated cardiac tissues. J Mol Cell Cardiol. 1983;15(4):233–243.

29.

Davidenko

Delmar

Oates

Jalife

. Electrophysiological actions of dantrolene sodium in isolated sinoatrial and atrioventricular nodes and in a model of ischemia. J Pharmacol Exp Ther. 1986;238(1):206–216.

30.

Salata

Jalife

. Effects of dantrolene sodium on the electrophysiological properties of canine cardiac Purkinje fibers. J Pharmacol Exp Ther. 1982;220(1):157–166.

31.

Chauhan

Downar

Nanthakumar

. Increased ventricular repolarization heterogeneity in patients with ventricular arrhythmia vulnerability and cardiomyopathy: a human in vivo study. Am J Physiol Heart Circ Physiol. 2006;290(1):H79–H86.

32.

Tusscher

Panfilov

. Alternans and spiral breakup in a human ventricular tissue model. Am J Physiol Heart Circ Physiol. 2006;291(3):H1088–H1100.

33.

Weiss

Chen

Karagueuzian

Garfinkel

. Ventricular fibrillation: how do we stop the waves from breaking? Circ Res. 2000;87(12):1103–1107.

34.

Wan

Laurita

Pruvot

Rosenbaum

. Molecular correlates of repolarization alternans in cardiac myocytes. J Mol Cell Cardiol. 2005;39(3):419–428.

35.

Wilson

Rosenbaum

. Mechanisms of arrythmogenic cardiac alternans. Europace. 2007;9(suppl 6):vi77–vi82.

36.

Díaz

O’Neill

Eisner

. Sarcoplasmic reticulum calcium content fluctuation is the key to cardiac alternans. Circ Res. 2004;94(5):650–656.

37.

Kameyama

Hirayama

Saitoh

Maruyama

Atarashi

Takano

. Possible contribution of the sarcoplasmic reticulum Ca(2+) pump function to electrical and mechanical alternans. J Electrocardiol. 2003;36(2):125–135.

38.

Sato

Shiferaw

Garfinkel

Weiss

Karma

. Spatially discordant alternans in cardiac tissue: role of calcium cycling. Circ Res. 2006;99(5):520–527.

39.

Cutler

Wan

Laurita

Hajjar

Rosenbaum

. Targeted SERCA2a gene expression identifies molecular mechanism and therapeutic target for arrhythmogenic cardiac alternans. Circ Arrhythm Electrophysiol. 2009;2(6):686–694.

40.

Garfinkel

Kim

Voroshilovsky

. Preventing ventricular fibrillation by flattening cardiac restitution. Proc Natl Acad Sci USA. 2000;97(11):6061–6066.

41.

Cao

Kim

. Spatiotemporal heterogeneity in the induction of ventricular fibrillation by rapid pacing: importance of cardiac restitution properties. Circ Res. 1999;84(11):1318–1331.

42.

Jin

Chen

Smith

Ideker

Huang

. Effects of procainamide and sotalol on restitution properties, dispersion of refractoriness and ventricular fibrillation activation patterns in pigs. J Cardiovasc Electrophysiol. 2008;19(10):1090–1097.

43.

Omichi

Zhou

Lee

. Effects of amiodarone on wave front dynamics during ventricular fibrillation in isolated swine right ventricle. Am J Physiol Heart Circ Physiol. 2002;282(3):H1063–H1070.

44.

Brack

Patel

Coote

. Autonomic modulation of electrical restitution, alternans and ventricular fibrillation initiation in the isolated heart. Cardiovasc Res. 2007;73(4):750–760.

45.

Goldhaber

Xie

Duong

Motter

Khuu

Weiss

. Action potential duration restitution and alternans in rabbit ventricular myocytes: the key role of intracellular calcium cycling. Circ Res. 2005;96(4):459–466.

46.

Boyett

Jewell

. Analysis of the effects of changes in rate and rhythm upon electrical activity in the heart. Prog Biophys Mol Biol. 1980;36(1):1–52.

47.

Uchida

Yashima

Gotoh

. Mechanism of acceleration of functional reentry in the ventricle: effects of ATP-sensitive potassium channel opener. Circulation. 1999;99(5):704–712.

48.

Nash

Bradley

Sutton

. Whole heart action potential duration restitution properties in cardiac patients: a combined clinical and modelling study. Exp Physiol. 2006;91(2):339–354.

49.

Cui

. Distinct restitution properties in vagally mediated atrial fibrillation and six-hour rapid pacing-induced atrial fibrillation. Cardiovasc Res. 2011;89(4):834–842.

50.

Kitagawa

Yamashita

Ito

Takaki

. Reversible effects of isoproterenol-induced hypertrophy on in situ left ventricular function in rat hearts. Am J Physiol Heart Circ Physiol. 2004;287(1):H277–H285.

51.

Zhang

Kimura

Nishiyama

. Cardiac oxidative stress in acute and chronic isoproterenol-infused rats. Cardiovasc Res. 2005;65(1):230–238.

52.

Shibata

Takeshita

Obata

. NHE-1 participates in isoproterenol-induced downregulation of SERCA2a and development of cardiac remodeling in rat hearts. Am J Physiol Heart Circ Physiol. 2011;301(5):H2154–H2160.

53.

Buyukokuroglu

Gulcin

Oktay

Kufrevioglu

. In vitro antioxidant properties of dantrolene sodium. Pharmacol Res. 2001;44(6):491–494.

54.

Bers

. Cardiac excitation-contraction coupling. Nature. 2002;415(6868):198–205.

55.

Nerbonne

Kass

. Molecular physiology of cardiac repolarization. Physiol Rev. 2005;85(4):1205–1253.

56.

Varró

Lathrop

Hester

Nánási

Papp

. Ionic currents and action potentials in rabbit, rat, and guinea pig ventricular myocytes. Basic Res Cardiol. 1993;88(2):93–102.

Effects of Dantrolene Treatment on Ventricular Electrophysiology and Arrhythmogenesis in Rats With Chronic β-Adrenergic Receptor Activation

Abstract

Keywords

Introduction

Materials and Methods

Experimental Animals

Surface Electrocardiogram Recording and Echocardiography Analysis

Histological Analysis

Isolation of Ventricular Myocytes and Measurement of [Ca2+]i Levels

Western Blotting Analysis

Preparation of Langendorff-Perfused Hearts

Data Acquisition and Stimulation Protocol

Monophasic action potential recording

S1 dynamic pacing, inducibility of APD alternans or VA, and construction of APDR curves

Statistical Analysis

Results

Changes in Cardiac Structural and Contractile Function

Characteristics of Ventricular Repolarization

Alterations in [Ca2+]i Levels and the Expression of Key SR Calcium Cycling Proteins

Changes in the APDR Curve and the APD Alternans or VA Thresholds

Discussion

Main Findings

The Abnormal Changes in ECG After Chronic β-Adrenoceptor Stimulation

Dantrolene Attenuated the Abnormal Changes in Ventricular Repolarization Induced by Chronic ISO Stimulation

Dantrolene Prevented APD Alternans via Increased Expression of Key SR Calcium Cycling Proteins in Rats That Received Chronic ISO Stimulation

Dantrolene Stabilized Ventricular APDR Properties to Suppress VA in Rats That Received Chronic ISO Stimulation

Dantrolene Improved the Cardiac Remodeling Induced by ISO Chronic Stimulation

Dantrolene Alleviated the [Ca2+]i Overload Induced by Chronic ISO Stimulation

Clinical Implications

Study Limitations

Conclusions

Footnotes

Author Contributions

Declaration of Conflicting Interests

Funding

References

Isolation of Ventricular Myocytes and Measurement of [Ca²⁺]_i Levels

S₁ dynamic pacing, inducibility of APD alternans or VA, and construction of APDR curves

Alterations in [Ca²⁺]_i Levels and the Expression of Key SR Calcium Cycling Proteins

Dantrolene Alleviated the [Ca²⁺]_i Overload Induced by Chronic ISO Stimulation